| pubmed-article:10859510 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0151779 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0035309 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0022265 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0035331 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:10859510 | lifeskim:mentions | umls-concept:C0205161 | lld:lifeskim |
| pubmed-article:10859510 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10859510 | pubmed:dateCreated | 2000-8-22 | lld:pubmed |
| pubmed-article:10859510 | pubmed:abstractText | To analyze whether an abnormal retinal function in patients with a cutaneous malignant melanoma was due to paraneoplastic retinopathy or due to isotretinoin or interferon-alpha. | lld:pubmed |
| pubmed-article:10859510 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10859510 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10859510 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10859510 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10859510 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10859510 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10859510 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10859510 | pubmed:issn | 0030-3755 | lld:pubmed |
| pubmed-article:10859510 | pubmed:author | pubmed-author:SoyerPP | lld:pubmed |
| pubmed-article:10859510 | pubmed:author | pubmed-author:FeiglBB | lld:pubmed |
| pubmed-article:10859510 | pubmed:author | pubmed-author:FaschingerCC | lld:pubmed |
| pubmed-article:10859510 | pubmed:copyrightInfo | Copyright 2000 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:10859510 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10859510 | pubmed:volume | 214 | lld:pubmed |
| pubmed-article:10859510 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10859510 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10859510 | pubmed:pagination | 271-6 | lld:pubmed |
| pubmed-article:10859510 | pubmed:dateRevised | 2007-9-17 | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:meshHeading | pubmed-meshheading:10859510... | lld:pubmed |
| pubmed-article:10859510 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10859510 | pubmed:articleTitle | Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma. | lld:pubmed |
| pubmed-article:10859510 | pubmed:affiliation | Department of Ophthalmology, University of Graz, Austria. beatrix.feigl@kfunigraz.ac.at | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:10859510 | pubmed:publicationType | Multicenter Study | lld:pubmed |
